BCRX Trading Below Director's Recent Buy Price
November 30, 2021 at 11:14 AM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 24, BioCryst Pharmaceuticals Inc's Director, Vincent Milano, invested $91,425.00 into 7,500 shares of BCRX, for a cost per share of $12.19..